DUBLIN--(BUSINESS WIRE)--The "U.S. In-Vitro Diagnostic Substances Market Analysis and Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The report provides on a detailed analysis of the U.S. in-vitro diagnostic substance market. It reveals the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains relevant data on the leading players in the industry.
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Market Overview
4. Most Promising Products
5. Most Promising Supplying Countries
6. Most Promising Overseas Markets
7. Production
8. Imports
9. Exports
10. Profiles Of Major Producers
- Abbott Diabetes Care
- Orasure Technologies
- Amag Pharmaceuticals
- Streck, Diasorin Inc.
- Diadexus
- Rapid Pathogen Screening
- Maine Biotechnology Services
- Saladax Biomedical
- Corgenix Medical Corporation
- George King Bio-Medical
- Princeton Biomeditech Corp
- Banyan Biomarkers
- Anatech
- Dxna LLC
- CD Diagnostics
- Akers Biosciences
- Helica Biosystems
- Green Mountain Antibodies
- Biospacific, Innominata
- Phase 2 Discovery
- Immuno Concepts
- Hepatochem
- Lifecare Medical International
- Horizon Diagnostic
- Immucor Gti Diagnostics
- Werfen USA
- Ivd Intermediate Holdings B Inc.
- Opko Diagnostics
- Horizon Diagnostic Inc
- Immucor Gti Diagnostics
- Werfen USA
- Ivd Intermediate Holdings B Inc.
- Opko Diagnostics
For more information about this report visit https://www.researchandmarkets.com/research/fd5njh/u_s_invitro?w=4
